Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-01-04 @ 2:54 AM
Study NCT ID:
NCT04115956
Status:
TERMINATED
Last Update Posted:
2022-03-28
First Post:
2019-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
Sponsor:
Oncopeptides AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-05
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-29
First Submit QC Date:
None
Study First Post Date:
2019-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-10
Last Update Post Date:
2022-03-28
Last Update Post Date Type:
ACTUAL